Olopatadine
Anti-allergy eye drop for itchy, watery eyes.
- Starts working
- Varies
- Half-life
- —
- In use since
- 1996
- Pregnancy
- Use with caution
Overview
Olopatadine drops relieve itchy allergic eyes within minutes and prevent symptoms all day. Some strengths are sold over the counter.
Conditions it's used for
How it works
Blocks histamine and calms allergy cells in the eye.
Olopatadine belongs to the Anti-allergy eye drops. How Anti-allergy eye drops work: block histamine and stop allergy cells releasing more of it.
Uses
- Allergic conjunctivitis
- Hay fever eye symptoms
Available as: eye drops, nasal spray.
Typical dose
- Adults
- One drop once or twice a day depending on strength.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Brief stinging
- Headache
- Taste disturbance
Serious — get medical help
Uncommon, but need prompt attention
- Allergic reactions (rare)
Warnings
- Remove contact lenses before use
Interactions
No major interaction patterns are recorded in the atlas. That doesn't mean there are none — always tell your pharmacist what else you take.
Check Olopatadine against your own medicinesPregnancy and breastfeeding
Use with caution
Limited data.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Pataday, Patanase (nasal)
- United Kingdom
- Opatanol
- India
- Olopat, Winolap
- Australia
- Patanol
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Can I use it with antihistamine tablets?
Yes; drops target the eyes directly.
Do I need a prescription for Olopatadine?
Olopatadine is sold without a prescription in many countries, though pack sizes and age limits apply. Rules differ by country.
Can I take Olopatadine during pregnancy?
Use with caution. Limited data. Always check with a doctor or midwife.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — S01GX09
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.